Cargando…

Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey

BACKGROUND: Atrial fibrillation (AF) can be managed with rhythm- or rate-control strategies. There are few data from routine clinical practice on the frequency with which each strategy is used and their correlates in terms of patients’ clinical characteristics, AF control, and symptom burden. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Chern-En, Naditch-Brûlé, Lisa, Brette, Sandrine, Silva-Cardoso, José, Gamra, Habib, Murin, Jan, Zharinov, Oleg J., Steg, Philippe Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723091/ https://www.ncbi.nlm.nih.gov/pubmed/26800084 http://dx.doi.org/10.1371/journal.pone.0147536

Ejemplares similares

Clinical Characteristics, Management, and Control of Permanent vs. Nonpermanent Atrial Fibrillation: Insights from the RealiseAF Survey
por: Murin, Jan, et al.
Publicado: (2014)

Cardiovascular risk profile and management of atrial fibrillation in India: Real world data from RealiseAF survey
por: Narasimhan, C., et al.
Publicado: (2016)

Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies
por: Naccarelli, Gerald V., et al.
Publicado: (2020)

Echocardiographic Parameters to Predict Atrial Fibrillation in Clinical Routine—The EAHsy-AF Risk Score
por: Sieweke, Jan-Thorben, et al.
Publicado: (2022)

Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial
por: Pisters, Ron, et al.
Publicado: (2014)

Indonesian registry on atrial fibrillation (OneAF)
por: Raharjo, Sunu Budhi, et al.
Publicado: (2021)

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)
por: De Caterina, Raffaele, et al.
Publicado: (2019)

Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE‐AF)
por: Ouali, Sana, et al.
Publicado: (2021)

Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success
por: Choi, Eue-Keun, et al.
Publicado: (2015)

Information Theory and Atrial Fibrillation (AF): A Review
por: Dharmaprani, Dhani, et al.
Publicado: (2018)

Baseline characteristics of edoxaban treatment in routine clinical practice for patients with non-valvular atrial fibrillation in China (ETNA-AF-China)
por: Guo, X Y, et al.
Publicado: (2023)

In-Hospital Mortality Among Critically Ill Patients With Atrial Fibrillation (AF) Versus Patients Without AF
por: Mehreen, Tooba, et al.
Publicado: (2021)

Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF
por: DeVore, Adam D., et al.
Publicado: (2016)

Atrial fibrillation and heart failure- results of the CASTLE-AF trial
por: Shah, Syed Raza, et al.
Publicado: (2018)

Atrial Fibrillation (AF) in Endurance Athletes: a Complicated Affair
por: Stergiou, Dimitrios, et al.
Publicado: (2018)

Atrial fibrillation virtual ward: reshaping the future of AF care
por: Kotb, A, et al.
Publicado: (2022)

Re‐CHARGE‐AF: Recalibration of the CHARGE‐AF Model for Atrial Fibrillation Risk Prediction in Patients With Acute Stroke
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Engagement of atrial fibrillation patients with the AF-EduApp, a new mobile application to support AF management
por: Knaepen, Lieselotte, et al.
Publicado: (2023)

Anticipation and Realisation
Publicado: (1920)

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study
por: de Groot, Joris R, et al.
Publicado: (2020)

Edoxaban treatment in atrial fibrillation in routine clinical care: One‐year outcomes of the prospective observational ETNA‐AF study in South Korean patients
por: Choi, Eue‐Keun, et al.
Publicado: (2023)

Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)
por: Steinberg, Benjamin A, et al.
Publicado: (2015)

Blood pressure control and components of the metabolic syndrome: the GOOD survey
por: Zidek, Walter, et al.
Publicado: (2009)

Continuous monitoring after atrial fibrillation ablation: the LINQ AF study
por: Wechselberger, Simon, et al.
Publicado: (2018)

Monitoring for AF: Identifying the Burden of Atrial Fibrillation and Assessing Post-Ablation
por: Passman, Rod S.
Publicado: (2017)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial
por: Shantsila, Eduard, et al.
Publicado: (2020)

Aldosterone Antagonism in Atrial Fibrillation: Implications for AF‐Predominant HFpEF
por: Ho, Jennifer E.
Publicado: (2020)

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry
por: Kiliszek, Marek, et al.
Publicado: (2021)

Age-dependent risk for thromboembolism in atrial fibrillation: The Fushimi AF registry
por: Esato, Masahiro, et al.
Publicado: (2022)

CHARGE-AF in a national routine primary care electronic health records database in the Netherlands: validation for 5-year risk of atrial fibrillation and implications for patient selection in atrial fibrillation screening
por: Himmelreich, Jelle C L, et al.
Publicado: (2021)

Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J‐ROCKET AF Trials) in Asian Patients With Atrial Fibrillation
por: Chan, Yi‐Hsin, et al.
Publicado: (2019)

Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries
por: Lim, Toon Wei, et al.
Publicado: (2023)

Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program
por: De Caterina, Raffaele, et al.
Publicado: (2021)

Renaissance & Baroque realisations
Publicado: (1991)

Decision Not to Realise Capital
Publicado: (1920)

Realising Aspirations in Implantology
por: Kolte, Abhay
Publicado: (2017)

Progression and regression in the left atrial substrate in patients with atrial fibrillation: the PROGRESS-AF study
por: Marcon, L, et al.
Publicado: (2023)

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
por: Wang, Kang-Ling, et al.
Publicado: (2015)

Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry
por: Yasuda, Ken, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q8r6echkb38u9anoqbv10nvns3